Abstract

The trend in morphine consumption in Italy and in Sicily was investigated, using sales of sustained-release formulations as an indicator. A slight increase in morphine consumption has been observed in the last few years. This trend was more evident in Sicily. Formulations with the lowest dose (10–30 mg) were more frequently used. Italian laws and restrictions concerning the medical use of opioids are the most severe in Europe. Although some countries have a high level of opioid consumption, the assertion that morphine consumption is an indicator of progress in cancer pain management is only valid in countries in which opioids are not generally used for other purposes, like in Italy. Continual medical education, postgraduate training courses, and the development of pilot programs of pain relief and palliative care may improve the knowledge of cancer pain management.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.